This 15.75-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.

This 30-minute, on-demand session from the ASAM 2025 Review Course reviews epidemiology, screening, complications of use, and unique treatment issues for adolescents, young adults, and the elderly.

This 1-hour, webinar is part of 4 four-session webinar series that will translate clinical guidelines into actionable strategies for safer benzodiazepine tapering. This webinar includes expert-led discussions and case-based applications that will cover Addressing Benzodiazepine Tapering Challenges.

In this case-based webinar recording, Dr. Emily Brunner, MD, and Dr. Maryann Amirshahi, PharmD, MD, MPH, PhD, provide strategies for managing complex benzodiazepine tapers, including personalized plans and effective communication.

In this webinar recording, Chinyere Ogbonna, MD, MPH, and Amy VandenBerg, PharmD, BCPP, FAAPP, offer guidance to primary care providers on managing benzodiazepine tapering, addressing common challenges, and withdrawal management.

In this webinar recording, Marcia Mecca, MD, discusses benzodiazepine tapering in older adults, focusing on care decisions, shared decision-making, and risks of long-term use.

This 90-minute on-demand session from the ASAM 56th Annual Conference addresses the narrowing gender gap in alcohol consumption with discussions on harm reduction in perinatal care, evidence-based adolescent interventions, and strategies tailored to senior women.

This 75-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 60-minute on-demand session from the ASAM 56th Annual Conference addresses the epidemiology of substance use disorders in older adults, key considerations for diagnosis and treatment, and innovative care models.

In this webinar recording, Donovan Maust, MD, MS, highlights key takeaways from The Joint Clinical Practice Guideline on Benzodiazepine Tapering and strategies to support safe, individualized tapers.